Author
Listed:
- Aoi Akitsu
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Graduate School of Science, The University of Tokyo
Research Fellow of the Japan Society for the Promotion of Science (JSPS)
Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency)
- Harumichi Ishigame
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Present address: RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan)
- Shigeru Kakuta
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Present address: Department of Biomedical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan)
- Soo-hyun Chung
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science)
- Satoshi Ikeda
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo)
- Kenji Shimizu
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science)
- Sachiko Kubo
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science)
- Yang Liu
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Present address: Renji Hospital Clinical Stem Cell Research Center, Shanghai Jiao Tong University School of Medicine, Shang Hai 200127, China)
- Masayuki Umemura
(Tropical Biosphere Research Center, University of the Ryukyus)
- Goro Matsuzaki
(Tropical Biosphere Research Center, University of the Ryukyus)
- Yasunobu Yoshikai
(Research Center for Prevention of Infectious Diseases, Medical Institute of Bioregulation, Kyushu University)
- Shinobu Saijo
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Present address: Department of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba 263-8522, Japan)
- Yoichiro Iwakura
(Laboratory of Molecular Pathogenesis, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo
Graduate School of Science, The University of Tokyo
Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency
Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science)
Abstract
Interleukin-17 (IL-17)-producing γδ T (γδ17) cells have been implicated in inflammatory diseases, but the underlying pathogenic mechanisms remain unclear. Here, we show that both CD4+ and γδ17 cells are required for the development of autoimmune arthritis in IL-1 receptor antagonist (IL-1Ra)-deficient mice. Specifically, activated CD4+ T cells direct γδ T-cell infiltration by inducing CCL2 expression in joints. Furthermore, IL-17 reporter mice reveal that the Vγ6+ subset of CCR2+ γδ T cells preferentially produces IL-17 in inflamed joints. Importantly, because IL-1Ra normally suppresses IL-1R expression on γδ T cells, IL-1Ra-deficient mice exhibit elevated IL-1R expression on Vγ6+ cells, which play a critical role in inducing them to produce IL-17. Our findings demonstrate a pathogenic mechanism in which adaptive and innate immunity induce an autoimmune disease in a coordinated manner.
Suggested Citation
Aoi Akitsu & Harumichi Ishigame & Shigeru Kakuta & Soo-hyun Chung & Satoshi Ikeda & Kenji Shimizu & Sachiko Kubo & Yang Liu & Masayuki Umemura & Goro Matsuzaki & Yasunobu Yoshikai & Shinobu Saijo & Yo, 2015.
"IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vγ6+γδ T cells,"
Nature Communications, Nature, vol. 6(1), pages 1-15, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8464
DOI: 10.1038/ncomms8464
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8464. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.